Crinetics Pharmaceuticals Inc (CRNX) with a beta value of 0.33 appears to be a promising investment opportunity.
A new trading day began on Tuesday, with Crinetics Pharmaceuticals Inc (NASDAQ: CRNX) stock price down -9.30% from the previous day of trading, before settling